Frequency and determinants of white coat hypertension in mild to moderate hypertension: A primary care-based study

American Journal of Hypertension

Volumn 12, Issue 3, 1999, Pages 251-259

  Martínez, María A ^a,b   García Puig, Juan ^a   Martín, Juan C ^a   Guallar Castillón, Pilar ^a   De Cárcer, Alvaro Aguirre ^a   Torre, Alberto ^a   Armada, Eduardo ^a   Nevado, Armando ^a   Madero, Rosario S ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b NONE   (Spain)

Author keywords

Ambulatory blood pressure; Left ventricular hypertrophy; Urinary albumin excretion; White coat hypertension

Indexed keywords

ADULT; AMBULATORY MONITORING; ARTICLE; BLOOD PRESSURE MONITORING; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROTEINURIA; WHITE COAT HYPERTENSION;

ADULT; AGED; ALBUMINURIA; BLOOD GLUCOSE; BLOOD PRESSURE DETERMINATION; BLOOD PRESSURE MONITORING, AMBULATORY; CHOLESTEROL; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; REGRESSION ANALYSIS; URIC ACID;

EID: 0033106063     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(98)00262-3     Document Type: Article

References (43)

1. Hypertension Detection and Follow-up Program Cooperative Group: Five years finding of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA 1979;242:2562-2571.
2. Medical Research Council Working Party: MRC trial of treatment of mild hypertension: Principal results. Br Med J 1985;291:97-104.
3. Management Committee of the Australian Therapeutic Trial in Mild Hypertension: Untreated mild hypertension. Lancet 1982;i:185-191.
4. Pickering TG, James GD, Boddie C, et al: How common is white coat hypertension? JAMA 1988;259:225-228.
5. Collins R, Peto R, MacMahon S, et al: Blood pressure, stroke and coronary heart disease. Part 2. Short term reductions in blood pressure: Overview of randomized drug trials in their epidemiological context. Lancet 1990;i:827-838.
6. Weber MA, Neutel JM, Smith DHG, Graettinger WF: Diagnosis of mild hypertension by ambulatory blood pressure monitoring. Circulation 1994;90:2291-2298.
7. Hoegholm A, Kristensen KS, Madsen NH, Svendesen TL: White coat hypertension diagnosed by 24-h ambulatory monitoring. Examination of newly diagnosed hypertensive patients. Am J Hypertens 1992;5:64-70.
8. Hernández del Rey R, Armario P, Sánchez P, et al: Frecuencia de la hipertensiáón de bata blanca en la hipertensiáón leve. Perfil de riesgo cardiovascular y afectaciáón orgáánica temprana (in Spanish). Med Clin (Barc) 1996;106:690-694.
9. Khoury S, Yarows SA, O'Brien TK, Sowers JR: Ambulatory blood pressure monitoring in a non academic setting. Effects of age and sex. Am J Hypertens 1992;5: 616-623.
10. Vinyoles E, de la Figuera M: Características clinicas de la hipertensión de bata blanca (in Spanish). Med Clin (Barc) 1995;105:287-291.
11. Márquez E, Ruiz R, Casado JJ, et al: La hipertensión de bata blanca en atención primaria. Estudio mediante monitorización ambulatoria de la presión arterial (in Spanish). Aten Primaria 1996;16:373-377.
12. Mayoral E, Lapetra J, Santos JM, et al: El efecto de bata blanca en atencióán primaria. Análisis en los pacientes con hipertensión arterial de nuevo diagnóstico (in Spanish). Med Clin (Barc) 1997;108:485-489.
13. Cavallini MC, Roman MJ, Pickering TG, et al: Is white coat hypertension associated with arterial disease or left ventricular hypertrophy? Hypertension 1995;26:413- 419.
14. Hoegholm A, Bang LE, Kristensen KS, et al: Microalbuminuria in 411 untreated individuals with established hypertension, white coat hypertension, and normotension. Hypertension 1994;24:101-105.
15. Verdecchia P, Schillaci G, Boldrini F, et al: Variability between current definitions of "normal" ambulatory blood pressure. Hypertension 1992;20:555-562.
16. Floras JS, Jones JV, Hassan MO, et al: Cuff and ambulatory blood pressure in subjects with essential hypertension. Lancet 1981;ii:107-109.
17. White WB, Schulman P, McCabe EJ, Dey HM: Average daily blood pressure, not office blood pressure, determines cardiac function in patients with hypertension. JAMA 1989;261:873-877.
18. Hoegholm A, Kristensens KS, Bang LE, et al: Left ventricular mass and geometry in patients with established hypertension and white coat hypertension. Am J Hypertens 1993;6:282-286.
19. Verdecchia P, Porcellati C, Schillaci G, et al: Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension 1994;24: 793-801.
20. Joint National Committee: The fifth report of the Joint National Committee on Detection, evaluation, and treatment of high blood pressure (JNC V). Arch Intern Med 1993;153:154-183.
21. British Hypertension Society: Blood pressure measurement. British Medical Journal Publications, London, 1991.
22. Bruce NG, Shaper AG, Walker M, Wannamethee G: Observer bias in BP studies. J Hypertens 1988;6:375- 380.
23. Staessen JA, Bieniaszewski L, O'Brien E, et al: Nocturnal blood pressure fall on ambulatory monitoring in a large international database. Hypertension 1997;29:30- 39.
24. Sahn DJ, Demaría A, Kisslo J, Weyman A, for the Committee on M-mode standardization of the American Society of Echocardiography: Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements. Circulation 1978;58:1072-1083.
25. Devereux RB, Reicheck N: Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55: 613-618.
26. Irgens-Moller L, Hemmingsen L, Holm J: Diagnostic value of microalbuminuria in pre-eclampsia. Clin Chim Acta 1986;157:295-298.
27. Verdecchia P, Schillaci G, Borgioni C, et al: White coat hypertension and white coat effect. Am J Hypertens 1995;8:790-798.
28. Pierdomenico SD, Lapenna D, Guglielmi MD, et al: Target organ status and serum lipids in patients with white coat hypertension. Hypertension 1995;26:801-807.
29. Pozuelo G, Molina L, Buitrago F: Confirmación diagnóstica de hipertensión arterial ligera mediante monitorización ambulatoria de la presión arterial (in Spanish). Aten Primaria 1993;12:197-200.
30. Stamler R, Shipley M, Elliot P, et al: High blood pressure in adults with less education: Some explanations from INTERSALT. Hypertension 1992;19:273-241.
31. Casale PN, Devereux RB, Milner M, et al: Value of echocardiographic measurements of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 1986;105:173-178.
32. Levy G, Garrison R, Savage DD, et al: Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham Heart Study. Ann Intern Med 1989;110:101-107.
33. Yudkin JS, Forrest RD, Jackson CA: Microalbuminuria as a predictor of vascular disease in non-diabetic subjects. Islington diabetes survey. Lancet 1988;ii:530-532.
34. Dansgaard DM, Froland A, Jorgensen OD, Mogensen CE: Microalbuminuria as a predictor of increased mortality in elderly people. Br Med J 1990;300:297-300.
35. Haffner SM, Seern MP, Gruber G, et al: Microalbuminuria: Potential marker for increased cardiovascular risk factor in non-diabetic subjects. Arteriosclerosis 1990;5: 727-731.
36. Perloff D, Sokolow M, Cowan R: The prognostic value of ambulatory blood pressures. JAMA 1983;249:2792- 2798.
37. Pickering TG: Ambulatory Monitoring and Blood Pressure Variability. Science Press Ltd., London, 1991, pp 13-19.
38. Julius S, Mejáa A, Jones K, et al: "White coat" versus "sustained" bordeline hypertension in Tecumseh, Michigan. Hypertension 1990;16:17-23.
39. Julius S, Jamerson K, Gudbrandsson T, Shork N: White coat hypertension: A follow-up. Clin Exp Hypertens 1992;A14:45-53.
40. Burnier M, Biollaz J, Magnin JL, et al: Renal sodium handling in patients with untreated hypertension and white coat hypertension. Hypertension 1993;23:496-502.
41. Glen SK, Elliot HL, Curzio JL, et al: White-coat hypertension as a cause of cardiovascular dysfunction. Lancet 1996;ii:654-657.
42. Ferrara LA, Guida L, Pasanisi F, et al: Isolated office hypertension and end-organ damage. J Hypertens 1997;15:979-985.
43. Bidlingmeyer I, Burnier M, Bidlingmeyer M, et al: Isolated office hypertension: A prehypertensive state. J Hypertens 1996:14:327-332.